"EbolaMoDRAD 2nd Consortium meeting took place on 14-15 March 2016 in Roma, Italy
"Bedside diagnostic tools to handle the current Ebola Virus Disease crisis. You will find our contact details for any additional question"
"With the EbolaMoDRAD project, we plan to investigate and focus our activities on developing robust, sensitive and rapid diagnostic tools for field investigation. "
"The primary expected impact of this programme is enhancing and upgrading scientific knowledge of various aspects of EVD, obtained by developing and applying new scientific tools. "

What is the Ebola virus?

Since 1976, Africa has faced sporadic outbreaks of Ebola Virus Disease (EVD), which results in horrible deaths and widespread fear. This current EVD crisis has caused more than 5,000 deaths within a few months in West Africa (with Guinea, Sierra Leone and Liberia being the most severely affected countries). The victims include numerous healthcare workers. The WHO states that this outbreak is a health bio-threat to Africa and other countries. It also stresses the need to mobilise resources in all countries around the world to fight this disease. There are major obstacles to tackling the crisis, such as the lack of rapid bedside diagnostics. To fill these gaps, we have established a multidisciplinary research consortium with a focus goal.

Natural epidemics and outbreaks of emerging infectious diseases are a growing problem internationally. Since 1976, Africa has faced sporadic outbreaks of EVD, which results in a horrible death and widespread fear. EVD is caused by the EBOV, which belongs to the family Filoviridae in the order Mononegavirales.

Filoviruses are enveloped, non-segmented and negative-stranded RNA viruses of varying morphology. EBOV disease remains a plague for the population of equatorial Africa, with an increase in the numbers of outbreaks and cases since the year 2000. EVD is characterised by high fever, prostration, diarrhoea and haemorrhagic manifestations, with a fatality rate of up to 90%. The disease is enzootic and causes severe disease in humans, chimpanzees and gorillas. EVD poses a great threat to public health due to its high mortality rate in man and its modes of transmission (animal-to-person and person-to-person).

cell

 

2014 Ebola crisis

No previous Ebola outbreak has been as large or persistent as the current epidemic in West Africa. To date, since March 2014, more than 10,000 people, including healthcare workers, have been killed by EBOV. Strikingly, the number of cases in the current outbreak has already exceeded the number from previous outbreaks combined. The World Health Organisation states that this outbreak in West Africa constitutes an ‘extraordinary event’, posing a public health threat to Africa and the rest of the planet. The United Nations also recognises this epidemic as a threat to Africa and the rest of the world, and stresses the necessity of extraordinary action from all countries and from different sectors of society, such as health, research, politics, finances, etc. In her speech on 20 September 2014 at the United Nations, Dr. Joanne Liu, International President of Médecins Sans Frontières, emphasised that “collaborative research and accessible data to all are required”.

map1

With the EbolaMoDRAD project, activities will be focused on developing robust, sensitive and rapid diagnostic tools for field investigation and laboratories with low technical settings. The EbolaMoDRAD project aims to build existing leading-edge expertise in Europe and Africa. It will bring together new networks of scientists to collaborate towards solving important public health issues concerning EVD, that are intractable to solve by individual groups and countries alone. In this programme, we will bring together several essential elements such as: clinical samples from West Africa, access to mobile laboratories in endemic areas of West Africa, novel approaches for detection of viral antigens, unique biosafety strategies for handling samples, unique facilities, SMEs and a long experience of transferring knowledge to develop a biosafe bedside diagnostic. Additionally this programme will also contribute to capacity building in affected areas and neighbouring countries.

 

image article1

News & Events

  • EbolaMoDRAD Final Consortium meeting, 11-12 December 2017, Lyon

    The final EbolaMoDRAD consortium meeting will take place in Lyon, in France, on December 11-12

    ...

    Read More ...

  • EbolaMoDRAD 3rd Workshop, 5-7 April 2017, Porton Down

    The 3rd workshop organized by the EbolaMoDRAD project was held in Porton Down, England, in the

    ...

    Read More ...

EbolaMoDRAD presentation leaflet

leaflet

 DOWNLOAD THE LEAFLET